Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
International Psychogeriatrics
|
January 11, 2026
Peripheral biomarkers associated with apathy and predicting response to methylphenidate: Secondary analysis of the Apathy in Dementia Methylphenidate Trial 2 (ADMET2) study
Krushnaa Sankhe, Myuri Ruthirakuhan, Ana C Andreazza, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
June 29, 2023
Heterogeneity of Response to Methylphenidate in Apathetic Patients in the ADMET 2 Trial
Krista L Lanctôt, Luc Rivet, Shankar Tumati, et al.
The American Journal of Psychiatry
|
January 16, 2016
Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial
Lon S Schneider, Constantine Frangakis, Lea T Drye, et al.
The New England Journal of Medicine
|
October 27, 2016
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation
, Richard K Albert, David H Au, et al.
Annals of the American Thoracic Society
|
November 1, 2017
The Long-Term Oxygen Treatment Trial for Chronic Obstructive Pulmonary Disease: Rationale, Design, and Lessons Learned
Roger D Yusen, Gerard J Criner, Alice L Sternberg, et al.
The Journal of Infectious Diseases
|
February 1, 2023
Symptom Duration and Resolution With Early Outpatient Treatment of Convalescent Plasma for Coronavirus Disease 2019: A Randomized Trial
Sheriza N Baksh, Sonya L Heath, Yuriko Fukuta, et al.
Chest
|
April 13, 2020
Association of Guideline-Recommended COPD Inhaler Regimens With Mortality, Respiratory Exacerbations, and Quality of Life: A Secondary Analysis of the Long-Term Oxygen Treatment Trial
Thomas Keller, Laura J Spece, Lucas M Donovan, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 24, 2023
Early Treatment, Inflammation and Post-COVID Conditions
Kelly A Gebo, Sonya L Heath, Yuriko Fukuta, et al.
Mbio
|
December 14, 2023
Erratum for Gebo et al., "Early antibody treatment, inflammation, and risk of post-COVID conditions"
Kelly A Gebo, Sonya L Heath, Yuriko Fukuta, et al.
Mbio
|
September 19, 2023
Early antibody treatment, inflammation, and risk of post-COVID conditions
Kelly A Gebo, Sonya L Heath, Yuriko Fukuta, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
International Psychogeriatrics
|
January 11, 2026
Peripheral biomarkers associated with apathy and predicting response to methylphenidate: Secondary analysis of the Apathy in Dementia Methylphenidate Trial 2 (ADMET2) study
Krushnaa Sankhe, Myuri Ruthirakuhan, Ana C Andreazza, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
June 29, 2023
Heterogeneity of Response to Methylphenidate in Apathetic Patients in the ADMET 2 Trial
Krista L Lanctôt, Luc Rivet, Shankar Tumati, et al.
The American Journal of Psychiatry
|
January 16, 2016
Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial
Lon S Schneider, Constantine Frangakis, Lea T Drye, et al.
The New England Journal of Medicine
|
October 27, 2016
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation
, Richard K Albert, David H Au, et al.
Annals of the American Thoracic Society
|
November 1, 2017
The Long-Term Oxygen Treatment Trial for Chronic Obstructive Pulmonary Disease: Rationale, Design, and Lessons Learned
Roger D Yusen, Gerard J Criner, Alice L Sternberg, et al.
The Journal of Infectious Diseases
|
February 1, 2023
Symptom Duration and Resolution With Early Outpatient Treatment of Convalescent Plasma for Coronavirus Disease 2019: A Randomized Trial
Sheriza N Baksh, Sonya L Heath, Yuriko Fukuta, et al.
Chest
|
April 13, 2020
Association of Guideline-Recommended COPD Inhaler Regimens With Mortality, Respiratory Exacerbations, and Quality of Life: A Secondary Analysis of the Long-Term Oxygen Treatment Trial
Thomas Keller, Laura J Spece, Lucas M Donovan, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 24, 2023
Early Treatment, Inflammation and Post-COVID Conditions
Kelly A Gebo, Sonya L Heath, Yuriko Fukuta, et al.
Mbio
|
December 14, 2023
Erratum for Gebo et al., "Early antibody treatment, inflammation, and risk of post-COVID conditions"
Kelly A Gebo, Sonya L Heath, Yuriko Fukuta, et al.
Mbio
|
September 19, 2023
Early antibody treatment, inflammation, and risk of post-COVID conditions
Kelly A Gebo, Sonya L Heath, Yuriko Fukuta, et al.
Page
of 4